MargheRITA (Remote Intelligence for Therapeutic Adherence)

Clinical trial NCT05260203 · COMPLETED

Trial details

NCT number: NCT05260203
Sponsor: Advice Pharma Group srl
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Multiple Myeloma Solitary Plasmacytoma Amyloidosis Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia T Cell Non-Hodgkin Lymphoma Lymphocytic Lymphoma Hodgkin Lymphoma B-cell Non Hodgkin Lymphoma Acute Myeloid Leukemia Myelodysplasia Chronic Myeloproliferative Disorder

Start date: 2022-06-04
Primary completion: 2023-01-16
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.